Abstract：【Objective】 To observe effect of total parathyroidectomy plus autologous transplantation on secondary hyperparathyroidism in maintenance hemodialysis patients【Methods】 The clinical data of 21 patients with secondary hyperparathyroidism who underwent hemodialysis and surgical treatment (total parathyroidectomy + autologous transplantation) in our hospital from July 2019 to August 2020 were analyzed retrospectively. The blood routine and biochemical test results (including hemoglobin, free calcium, phosphorus, parathyroid hormone, alkaline phosphatase, etc.), clinical symptoms (bone pain, skin pruritus, restless legs syndrome, sleep disorder, etc.) and treatment plan of patients at different stages before and after operation (1 day, 1 week, 1 month, 3 months, 6 months, 12 months) were collected and statistically analyzed. 【Results】Compared with before operation, blood calcium, blood phosphorus, iPTH and ALP decreased significantly in all patients (P<0.05). The symptoms of postoperative patients such as bone pain, skin pruritus, restless legs syndrome and sleep were relieved to varying degrees. The blood pressure of postoperative patients was better controlled than that before operation, and the dose of erythropoietin required to maintain the target hemoglobin level was significantly reduced. 【Conclusion】Total parathyroidectomy plus autotransplantation can significantly improve calcium/ phosphorus metabolism disorder and renal anemia in patients with secondary hyperparathyroidism after hemodialysis, reduce blood pressure, parathyroid hormone and alkaline phosphatase levels, and effectively alleviate clinical symptoms such as bone pain, skin pruritus, restless legs syndrome and sleep disorder.
刘峻, 覃娇, 文锐, 周定刚. 甲状旁腺全切加自体移植术对血液透析患者继发性甲状旁腺功能亢进的影响[J]. 医学临床研究, 2022, 39(4): 582-585.
LIU Jun, QIN Jiao, WEN Rui, et al. Effect of Total Parathyroidectomy plus Autologous Transplantation on Secondary Hyperparathyroidism in Maintenance Hemodialysis Patients. JOURNAL OF CLINICAL RESEARCH, 2022, 39(4): 582-585.
[1] LEVY A R, XING S, BRUNELLI S M,et al. Symptoms of secondary hyperparathyroidism in patients receiving maintenance hemodialysis:a prospective cohort study[J].Am J Kidney Dis,2020,75(3):373-383.
[2] Kidney Disease:Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) [J].Kidney Int Suppl,2009,76(113):S1-S130.
[3] 国家肾脏疾病临床医学研究中心. 中国慢性肾脏病矿物质和骨异常诊治指南概要[J].肾脏病与透析肾移植杂志, 2019, 28(1):52-57.
[4] 王绍勇,谭忠麒,袁锋,等.PTX加自体移植术治疗血液透析SHPT的疗效分析[J].西南国防医药,2019,29(4):23-26.
[5] SUSANTITAPHONG P, VADCHARAVIVAD S, SUSOMBOON T, et al. The effectiveness of cinacalcet:a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism[J].Ren Fail,2019,41(1):326-333.
[6] RODRÍGUEZ-ORTIZ M E, PENDÓN-RUIZ DE MIER M V, RODRÍGUEZ M. Parathyroidectomy in dialysis patients:Indications, methods, and consequences[J].Semin Dial,2019,32(5):444-451.
[7] STEINL G K, KUO J H. Surgical management of secondary hyperparathyroidism[J].Kidney Int Rep,2020,6(2):254-264.
[8] 杜书同, 马伟军, 李红芬,等. 甲状旁腺切除术对维持性血液透析患者血压的影响[J].中国中西医结合肾病杂志, 2017, 18(10):885-888.
[9] 林新伟, 杨宇, 赵茹. 甲状旁腺切除前后维持性血液透析患者的血压和血钙变化及其相关分析[J].中国血液净化, 2017, 16(7):469-473.
[10] TANAKA M, KOMABA H, FUKAGAWA M. Emerging association between parathyroid hormone and anemia in hemodialysis patients[J].Ther Apher Dial,2018,22(3):242-245.
2022, Vol. 39 
